Cardio Technologies' CardioSupport Heart-Assist Trials To Begin In Early 2000
This article was originally published in The Gray Sheet
Cardio Technologies' CardioSupport System minimally invasive heart-assist device is anticipated to begin prospective, randomized, controlled clinical trials in the U.S. late in the first quarter of 2000 following submission and clearance of an FDA investigational device exemption in the near future, the firm says.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.